Bayer to Spend Up to $4 Billion for AskBio’s Gene Therapies

Bookmark
(Bloomberg) -- Bayer AG agreed to acquire U.S. biotech company Asklepios BioPharmaceutical Inc. for as much as $4 billion, bolstering its pharma division with experimental gene therapies before pat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.